Read Anywhere and on Any Device!

Subscribe to Read | $0.00

Join today and start reading your favorite books for Free!

Create Free Account

FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies

5/5 ( ratings)

In its decades-long effort to assure the safety, efficacy, and security of medicines and other products, the Food and Drug Administration has struggled with issues of funding, proper associations with industry, and the balance between consumer choice and consumer protection. Today, these challenges are compounded by the pressures of globalization, the introduction of novel technologies, and fast-evolving threats to public health. With essays by leading scholars and government and private-industry experts, FDA in the Twenty-First Century addresses perennial and new problems and the improvements the agency can make to better serve the public good.

The collection features essays on effective regulation in an era of globalization, consumer empowerment, and comparative effectiveness, as well as questions of data transparency, conflicts of interest, industry responsibility, and innovation policy, all with an emphasis on pharmaceuticals. The book also intervenes in the debate over off-label drug marketing and the proper role of the FDA before and after a drug goes on the market. Dealing honestly and thoroughly with the FDA's successes and failures, these essays rethink the structure, function, and future of the agency and the effect policy innovations may have on regulatory institutions abroad.

Pages: 568

Format: Hardcover

Publisher: Columbia University Press

Release: September 08, 2015

ISBN: 0231171188

ISBN 13: 9780231171182

FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies

5/5 ( ratings)

In its decades-long effort to assure the safety, efficacy, and security of medicines and other products, the Food and Drug Administration has struggled with issues of funding, proper associations with industry, and the balance between consumer choice and consumer protection. Today, these challenges are compounded by the pressures of globalization, the introduction of novel technologies, and fast-evolving threats to public health. With essays by leading scholars and government and private-industry experts, FDA in the Twenty-First Century addresses perennial and new problems and the improvements the agency can make to better serve the public good.

The collection features essays on effective regulation in an era of globalization, consumer empowerment, and comparative effectiveness, as well as questions of data transparency, conflicts of interest, industry responsibility, and innovation policy, all with an emphasis on pharmaceuticals. The book also intervenes in the debate over off-label drug marketing and the proper role of the FDA before and after a drug goes on the market. Dealing honestly and thoroughly with the FDA's successes and failures, these essays rethink the structure, function, and future of the agency and the effect policy innovations may have on regulatory institutions abroad.

Pages: 568

Format: Hardcover

Publisher: Columbia University Press

Release: September 08, 2015

ISBN: 0231171188

ISBN 13: 9780231171182

More books from I. Glenn Cohen

Identified versus Statistical Lives: An Interdisciplinary Perspective (Population-Level Bioethics)

4.3/5 ( ratings)

Human Subjects Research Regulation: Perspectives on the Future

3.3/5 ( ratings)

Protecting and Promoting the Health of NFL Players: Legal and Ethical Analysis and Recommendations

Law, Religion, and Health in the United States

Bioethics and Public Health Law (Aspen Select Series)

Readings in Comparative Health Law and Bioethics, Third Edition

The Globalization of Health Care: Legal and Ethical Issues

Health Care Law and Ethics (Aspen Casebook Series)

The Future of Medical Device Regulation: Innovation and Protection

The Oxford Handbook of U. S. Health Law

Specimen Science: Ethics and Policy Implications

Rate this book!

Write a review?